Preparative Chromatography Technique in the Removal of Isostructural Genotoxic Impurity in Rizatriptan: Use of Physicochemical Descriptors of Solute and Adsorbent†

2009 ◽  
Vol 13 (4) ◽  
pp. 683-689 ◽  
Author(s):  
Srinivasula Reddy Maddula ◽  
Manoj Kharkar ◽  
Kushal Manudhane ◽  
Sandeep Kale ◽  
Abijar Bhori ◽  
...  
Keyword(s):  
Preparative Chromatography ◽  
Physicochemical Descriptors

Discovery of New Phosphoinositide 3-kinase Delta (PI3Kδ) Inhibitors via Virtual Screening using Crystallography-derived Pharmacophore Modelling and QSAR Analysis

2019 ◽  
Vol 15 (6) ◽  
pp. 588-601 ◽  
Author(s):  
Mahmoud A. Al-Sha'er ◽  
Rua'a A. Al-Aqtash ◽  
Mutasem O. Taha
Keyword(s):  
Virtual Screening ◽  
Inflammatory Diseases ◽  
Qsar Model ◽  
Qsar Analysis ◽  
Pharmacophore Modelling ◽  
Physicochemical Descriptors ◽  
Qsar Modelling ◽  
Ic50 Values ◽  
Phosphoinositide 3 Kinase ◽  
Pharmacophore Models

<P>Background: PI3K&#948; is predominantly expressed in hematopoietic cells and participates in the activation of leukocytes. PI3K&#948; inhibition is a promising approach for treating inflammatory diseases and leukocyte malignancies. Accordingly, we decided to model PI3K&#948; binding. </P><P> Methods: Seventeen PI3K&#948; crystallographic complexes were used to extract 94 pharmacophore models. QSAR modelling was subsequently used to select the superior pharmacophore(s) that best explain bioactivity variation within a list of 79 diverse inhibitors (i.e., upon combination with other physicochemical descriptors). </P><P> Results: The best QSAR model (r2 = 0.71, r2 LOO = 0.70, r2 press against external testing list of 15 compounds = 0.80) included a single crystallographic pharmacophore of optimal explanatory qualities. The resulting pharmacophore and QSAR model were used to screen the National Cancer Institute (NCI) database for new PI3Kδ inhibitors. Two hits showed low micromolar IC50 values. </P><P> Conclusion: Crystallography-based pharmacophores were successfully combined with QSAR analysis for the identification of novel PI3K&#948; inhibitors.</P>

Elaboration of Novel TTK1 Inhibitory Leads via QSAR-Guided Selection of Crystallographic Pharmacophores Followed By In vitro Assay

2020 ◽  
Vol 16 ◽  
Author(s):  
Mahmoud A. Al-Sha'er ◽  
Mutasem O. Taha
Keyword(s):  
Standard Error ◽  
Qsar Model ◽  
Qsar Modeling ◽  
Vitro Assay ◽  
Physicochemical Descriptors ◽  
Qsar Models ◽  
Ic50 Values ◽  
Pharmacophore Hypotheses ◽  
Selection Of

Introduction: Tyrosine threonine kinase (TTK1) is a key regulator of chromosome segregation. TTK targeting received recent concern for the enhancement of possible anticancer therapies. Objective: In this regard we employed our well-known method of QSAR-guided selection of best crystallographic pharmacophore(s) to discover considerable binding interactions that anchore inhibitors into TTK1 binding site. Method:Sixtyone TTK1 crystallographic complexes were used to extract 315 pharmacophore hypotheses. QSAR modeling was subsequently used to choose a single crystallographic pharmacophore that when combined with other physicochemical descriptors elucidates bioactivity discrepancy within a list of 55 miscellaneous inhibitors. Results: The best QSAR model was robust and predictive (r2(55) = 0.75, r2LOO = 0.72 , r2press against external testing list of 12 compounds = 0.67), Standard error of estimate (training set) (S)= 0.63 , Standard error of estimate (testing set)(Stest) = 0.62. The resulting pharmacophore and QSAR models were used to scan the National Cancer Institute (NCI) database for new TTK1 inhibitors. Conclusion: Five hits confirmed significant TTK1 inhibitory profiles with IC50 values ranging between 11.7 and 76.6 micM.

scholarly journals NetCleave: an open-source algorithm for predicting C-terminal antigen processing for MHC-I and MHC-II

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Pep Amengual-Rigo ◽  
Victor Guallar
Keyword(s):  
Open Source ◽  
Antigen Processing ◽  
High Accuracy ◽  
Biological Processes ◽  
Mhc I ◽  
Mhc Ii ◽  
Prediction Tools ◽  
Immunogenic Peptides ◽  
Physicochemical Descriptors ◽  
Peptide Presentation

AbstractAntigens presented on the cell surface have been subjected to multiple biological processes. Among them, C-terminal antigen processing constitutes one of the main bottlenecks of the peptide presentation pathways, as it delimits the peptidome that will be subjected downstream. Here, we present NetCleave, an open-source and retrainable algorithm for the prediction of the C-terminal antigen processing for both MHC-I and MHC-II pathways. NetCleave architecture consists of a neural network trained on 46 different physicochemical descriptors of the cleavage site amino acids. Our results demonstrate that prediction of C-terminal antigen processing achieves high accuracy on MHC-I (AUC of 0.91), while it remains challenging for MHC-II (AUC of 0.66). Moreover, we evaluated the performance of NetCleave and other prediction tools for the evaluation of four independent immunogenicity datasets (H2-Db, H2-Kb, HLA-A*02:01 and HLA-B:07:02). Overall, we demonstrate that NetCleave stands out as one of the best algorithms for the prediction of C-terminal processing, and we provide one of the first evidence that C-terminal processing predictions may help in the discovery of immunogenic peptides.

Sign in / Sign up

Export Citation Format

Share Document